MacuSight

Sirolimus-based product as a next-generation therapeutic for the treatment/prevention of wet AMD and the treatment of diabetic macular edema

Start Trial Get Full Profile

There’s no risk. Start your trial today to see profiles of MacuSight plus 5086 other startups.

Start Free 7 Day Trial Now

Learn More About MacuSight

Technology/product details

Competing Startups

More

Our Clients